Caption Management, LLC Curis Inc Transaction History

Caption Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$6.94 - $8.85 $8,328 - $10,620	-1,200 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $819,142 - $1.79 Million	-109,952 Reduced 98.92%	1,200 $9,000
Q1 2021 May 17, 2021	BUY	$8.78 - $12.8 $975,914 - $1.42 Million	111,152 New	111,152 $1.26 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.